GSK Consumer Healthcare Q3 profit up 36.7% at Rs 131.85 crore
Advertisement
New Delhi: GlaxoSmithKline (GSK) Consumer Healthcare Ltd today reported a 36.75 per cent increase in its standalone net profit to Rs 131.85 crore for the third quarter ended on December 31, 2015 as the company has gained shares in the health food drink category.
The company had reported a net profit of Rs 96.41 crore for the October-December period a year ago, GSK said in a BSE filing.
Net sales of the company during the period under review were up 1.39 per cent to Rs 988.77 crore as against Rs 975.17 crore in the corresponding period last fiscal.
The company had reported a net profit of Rs 96.41 crore for the October-December period a year ago, GSK said in a BSE filing.
Net sales of the company during the period under review were up 1.39 per cent to Rs 988.77 crore as against Rs 975.17 crore in the corresponding period last fiscal.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.